REGENXBIO - Stock Price History | RGNX
Historical daily share price chart and data for REGENXBIO since 2021 adjusted for splits. The latest closing stock price for REGENXBIO as of September 27, 2021 is 43.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high REGENXBIO stock closing price was 82.15 on July 10, 2018.
- The REGENXBIO 52-week high stock price is 50.26, which is 15.2% above the current share price.
- The REGENXBIO 52-week low stock price is 26.40, which is 39.5% below the current share price.
- The average REGENXBIO stock price for the last 52 weeks is 37.18.
|REGENXBIO Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.